The Cancer Profile Test

Last time, in addition to emphasizing the importance of detecting cancer as early as possible, I also told you how and why conventional diagnostic tests for cancer so often fail to do so. Today I want to tell you about a simple combination blood and urine test that is able to detect changes in your body’s biochemistry that are early warning signs that you may be on the way to developing cancer.

The test is called the Cancer Profile© and is available from American Metabolic Laboratories here in the United States. Developed by Emil Schandl, PhD, AML’s founder, who has a master’s degree in both biochemistry and enzymology and a doctorate in molecular genetics, the test is based on the scientific fact that certain detectable changes in biochemistry occur as the human body progresses from a healthy state towards states that are precancerous and cancerous.

How The Cancer Profile Test Works

The Cancer Profile test incorporates eight tests which, combined, provide a far more accurate indication of whether or not a person’s biochemistry is shifting towards an unhealthy state than if the tests were done separately. The test measures levels of thyroid-stimulating hormone (TSH), and indicator of thyroid function (low thyroid function, or hypothyroidism, can predispose one to developing cancer) ; DHEA-S, a hormone produced by the adrenal gland that serves as an indicator of adrenal and immune function, as well as a marker for cancer; gamma-glutamyltranspeptidase (GGTP), an enzyme marker for overall liver function (healthy liver function is essential for protecting against cancer); and the cancer markers CEA (carcinoembryonic antigen), PHI (phosphohexose isomerase enzyme), and HCG (human chorionic gonadotropin), the last of which is measured using three different methods to ensure the best possible accuracy.

Based on his many years of research, Dr. Shandl observed that the substances his Cancer Profile test measures tend to become elevated at least 10 or more years before cancer can be detected using conventional screening tests. This is not surprising, since we now know that, in the vast majority of cases, it takes years before cancer develops to the point where it becomes a threat to health. Because of this long timeline, alternative cancer specialists realize that, by looking for shifts in biochemistry such as those the Cancer Profile measures, they can help their patients actually avoid cancer before it gains a foothold inside their bodies, using highly effective approaches such as dietary and lifestyle changes, along with nutritional supplements, detoxification therapies, and other modalities, as necessary.

If you read my last article on the need for early detection, you will recall what I mentioned about the importance of sensitivity and specificity. Briefly put, sensitivity and specificity in combination with each other determine how accurate a cancer screening test is. Sensitivity refers to the probability that a test will show a positive result when cancer actually exists, while specificity refers to the probability that a negative test result will occur when no cancer exists. A test that has high sensitivity and high specificity is far more useful than tests for which one or both of these measures are lower.

Dr. Shandl developed the Cancer Profile test for precisely this reason. He wanted to ensure a high level of accuracy, which simply cannot be achieved when doctors rely on only one of the markers alone. For example, despite the fact that numerous scientific studies show that HCG levels in the body become elevated when cancer cells are present in the body, other studies have found that tests that screen for HCG alone can often fail to detect such increases in elevations, usually because, even though the levels have risen, they may not have done so at levels high enough to be detected. As a result, HCG screening tests by themselves account for approximately 30 percent false negative results. (A false negative reading means a patient is told he or she does not have cancer when in reality cancer is present but was not detected.)

Similarly, other studies have shown that screening for either CEA or PHI alone can also lead to false negative results, whereas when both of these markers are measured, the overall accuracy of such testing increases significantly.

Given these facts, you can understand the advantages that the Cancer Profile test offers in comparison to stand-alone marker tests. Simply put, what a single cancer market test can often miss, the combination of markers included in the Cancer Profile will usually find with far more accuracy. (Testing has shown that the Cancer Profile has an overall accuracy rate of between 87 and 97 percent, depending on the type of cancer that a person may be developing, which far exceeds the rates of most other cancer screening tests.) Even more significantly, as I said, it can detect cancer far earlier than conventional cancer tests.

Another significant advantage of Dr. Shandl’s test is that, unlike stand-alone marker tests that typically screen for only one type of cancer and therefore fail to detect others types of cancer that might be present, the Cancer Profile is able to detect whether cancer is present in general. This saves time and money and can potentially also save lives. As with other blood screening tests for cancer, however, the Cancer Profile by itself cannot definitively prove that cancer is present. Such confirmation can only be obtained with further testing methods, which also can determine which type of cancer a person has.

Finally, another major benefit of the Cancer Profile test is that is can not only be used to screen for cancer, but also to monitor how well patients’ cancer treatments are working. This is vitally important because no cancer treatment, whether alternative or conventional, works 100 percent of the time. This means that even the most promising treatments with the highest success rates are incapable of helping everyone. By using the Cancer Profile test to monitor how well their treatments are working, physicians can quickly know whether they are on the right track for each individual patient, or whether they need to change what they are doing before it is too late. In addition, if surgery is deemed necessary to remove cancerous tumors, the Cancer Profile can be used prior to surgical procedures to provide patients and their physicians with a benchmark to determine whether or not the surgery was successful. Following surgery, a follow-up Profile test can be given. If surgery was indeed successful, the Profile will confirm that by showing lowered levels of the cancer markers it measures. If the markers stay at the same level as before, or continue to rise, then doctors will quickly know that their patients need additional treatment.

Just as importantly, physicians can use the Cancer Profile to monitor how well their patients who achieve remission of their cancer are maintaining their health. As anyone who has had cancer knows (including me), once cancer strikes, it can strike again. Here too conventional cancer tests are often ineffective due to their inability to indicate in a timely fashion whether cancer is returning. For this reason, patients and their physicians alike are often forced to “watch and wait,” hoping that the patient’s remain cancer-free. Unfortunately, too many times cancer does return, and when it does so it is often worse than it was originally, making further treatment more challenging. By using the Cancer Profile, physicians don’t have to wait to detect signs of relapse. Instead, they can see from the Profile how well their cancer patients are doing and, if necessary, take appropriate action much earlier, before the cancer recurrence becomes more serious.


How You Can Obtain the Cancer Profile Test

Despite the benefits that the Cancer Profile test offers, as well as the fact that physicians and patients from all across the United States and around the world have made use of it, the test still remains relatively unknown. For this reason, I urge you not to wait for doctors to find out about it on their own. Instead, learn more about it yourself. You can do so by contacting:

American Metabolic Laboratories
1818 Sheridan Street, Suite 102
Hollywood, FL 33020
(954) 929-4814
http://americanmetaboliclaboratories.net

Your doctor can order the test for you, or you can do it yourself by contacting American Metabolic Laboratories directly. After you receive your results, you can also schedule a free phone consultation with one of the lab’s trained representatives.

The Need To Detect Cancer Early: Why Conventional Cancer Tests Are Not the Answer

One of the main reasons that cancer is such a costly disease—both in terms of human suffering and in the financial cost involved in treating it—is because by and large it is not detected early enough.

When it comes to early detection, conventional medicine is well behind alternative cancer approaches. That’s because conventional diagnostic cancer tests look only for signs of cancer tumors. This is true whether the screening methods are measuring cancer markers or looking for signs of tumors directly, such as through CT scans, MRIs, x-rays, etc.

Most people do not realize that it takes years, and in some cases even decades before cancer develops into a visible tumor that conventional screening can detect. By then, the challenge of treating cancer successfully is more difficult and costly. That’s because, during all of the time that tumors are not detectable by conventional means, cancer is still active in the body.

Since the conventional cancer establishment often refers to its approach to cancer as a “war,” think of detection this way:

In war, doesn’t it make sense to be aware of your enemy before he can come ashore and strike, rather than to wait for years while he stealthily infiltrates your defenses before he strikes in full force? Obviously your chances of defeating your enemy are much greater if you can stop him in his tracks before he has a chance to leave his homeland. Similarly, alternative and integrative cancer physicians recognize that the earliest possible detection of cancer greatly increases the chances of their patients’ long-term recovery and survival. Just as importantly, early detection makes treating cancer far less costly, compared to when it’s detected later on.

Limitations of Conventional Cancer Tests


Conventional cancer tests have a number of limitations, starting with the fact that, as I said, cancer must have developed into a tumor before they can successfully detect it. (For the purposes of this article, I am referring here to “solid state” cancers, meaning those for which tumor formation is involved. Nearly all types of cancer fall into this category, with two notable exceptions: leukemias and lymphomas, such as Hodgkin’s disease and non-Hodgkins lymphoma.) As mentioned, this means that cancer has to be present in the body for a long time before conventional cancer tests can detect it. And even then, small tumors can be missed by such tests, escaping detection until they grow larger, by which time cancer has progressed even further.

In addition, as I’ve written about in the past, a number of conventional cancer tests, such as x-rays and CT scans, are capable of causing cancer themselves due to the radiation they emit when patients are tested.

For this reason, conventional cancer specialists also rely on cancer markers to screen patients for cancer. A cancer marker refers to any of a variety of blood tests that measure the level of a protein material or other chemical that is produced by cancer cells. Marker levels become elevated in the presence of a cancerous tumor.

There are different cancer markers for different kinds of cancer. For example, the marker CEA (carcino-embryonic antigen) is used to screen for colon cancer, while CA 15-3 or CA 27-29 are used to screen for breast cancer. Other common cancer markers are CA 125, used to screen for ovarian cancer, and the PSA (prostate-specific antigen) test for men, which until recently was commonly relied upon by conventional physicians to screen for prostate cancer. (Recent research has shown that the PSA test may not be an accurate indicator of prostate cancer, to the points where its developer has now called on physicians to stop relying upon it for this purpose. The PSA test continues to be an accurate indicator for enlargement of the prostate gland or BPH.)

The most obvious limitation of conventional cancer marker tests is the fact that each of them can only be used to screen for one particular type of cancer. This means, for example, that a woman screened for breast cancer may be given a clean bill of health if her cancer markers show a low score all the while that she may have colon or another type of cancer that the markers cannot screen for.

Nor is that the only problem. Cancer markers can produce inaccurate results known as false positives and false negatives. A false positive results in patients being told they have cancer when in fact they don’t, while a false negative can result in people with cancer being told they are cancer-free. Obviously, either type of false reading is not a good outcome.

False positive and false negative outcomes from cancer marker tests are related to two statistical measures that determine a screening test’s usefulness. These measures are known as sensitivity and specificity. Sensitivity refers to the probability that a test will show a positive result when cancer actually exists, while specificity refers to the probability that a negative test result will occur when no cancer exists. A test that has high sensitivity and high specificity is far more useful than tests for which one or both of these measures are lower. Unfortunately, too many conventional cancer marker tests fall into this latter category. They include the PSA test, as well as the CA 27-29 and CEA tests, among others.

False negative outcomes are also quite high with the traditional PAP smear test, which is used to screen for cancer of the cervix. This test examines stained cells from the mucous membrane of the cervix for signs of precancerous changes. Pre-cancer of the cervix is called cervical dysplasia. When detected early enough, it is almost always reversible, but once it progresses into malignancy and becomes invasive it is much more difficult to treat. It is estimated that a full one-third of women who die from cervical cancer do so because it was not accurately detected soon enough for successful treatment to begin.

Given all of the above, you are probably wishing that there were accurate and noninvasive tests that could screen for cancer in its earliest stages, far ahead of the conventional diagnostic tests I’ve mentioned, that could also screen for multiple types of cancer at once, instead of patients needing to have multiple types of tests to know whether or not cancer is present in their bodies.

Fortunately these types of tests do exist, and more and more alternative physicians are now making use of them even though both tests are still ignored by their conventional counterparts. In future articles I will tell you about two of these tests, one from Germany and one that is available right here in the United States, and I will also let you know how you can obtain them. Stay tuned.

Until then, remember this: When it comes to cancer, prevention is your best option, followed by the earliest possible detection methods.

Cancer and Your Immune System

It may surprise you to know that cancer cells are produced in your body each and every day, to the point where they even form tumors. That’s because each of us is constantly being exposed to carcinogens in our food, air and water supply. Fortunately, your body has a powerful weapon that is constantly on the alert for such abnormal cells and is quick to destroy them once they are found. What is this powerful weapon?

Your immune system!

When you are healthy, the cancer cells and tumors mentioned above never make it past the microscopic stage. Instead, they disappear before you even have a chance to know they exist. According to conventional oncologists, this disappearing act is known as “spontaneous regression.” But in reality it’s all due to the ability of the immune system to identify cancer cells early, before they can multiply, and quickly eliminate them as part of the overall protective role that the immune system performs as it helps to maintain your overall health.

Based on these facts, three things are very clear with regard to cancer:

1) The health of immune system is one of the most important factors that determine cancer patients’ survival.

2) The presence of cancer cells in the body is far less important than the immune system’s ability to properly identify and eliminate such cells, even when they are few in number.

3) Cancer takes hold in the body largely as a result of a functional breakdown or imbalance in the immune system, which can occur as a result of many factors, including poor diet, nutritional deficiencies, chronic exposure to toxins that over time overwhelm the immune system, unhealthy lifestyle choices (smoking, alcohol or drug abuse, etc), chronic stress, and unresolved emotional issues, to name just a few.


How Your Immune System Fights Cancer

When functioning properly your immune system protects against cancer in a number of important ways. First, it assesses whether normal cells have been transformed into cancer cells. This task is performed by specialized white blood cells known as T lymphocytes, or T cells. T cells are produced by the thymus glad and travel throughout the body where they seek out abnormal cells and foreign proteins known as tumor-associated antigens that are released by tumor cells.

If cancer cells are present, certain types of T cells signal other types of white blood cells to spring into action. These include B cells that produce antibodies that neutralize foreign matter in both blood and tissues, as well as other lymphocytes that produce anticancer chemicals known as cytokines. Cytokines act like a natural form of chemotherapy and include tumor necrosis factor, interleukin, and interferon. Unlike chemotherapy drugs, cytokines do their work without harming healthy cells.

Other cancer fighters in your immune system’s arsenal include natural killer (NK) cells and macrophages. NK cells are one of your body’s most immediate and powerful agents for protecting against cancer. A specialized class of lymphocytes, NK cells lock onto cancer cell sites and destroy malignant cells before they can multiply and spread. NK cells are especially important in the early stages of cancer, when they descend directly upon tiny tumors to devour them or cause them to disintegrate before the tumors can grow and start to harm the body. NK cells have little effect against large tumors, however.

Like NK cells, macrophages also destroy cancer cells by ingesting them. They also support your body’s detoxification system by scavenging for waste and debris, and help to regulate cell reproduction as well as the activity of other immune cells. Research has shown a direct correlation between increased macrophage activity and a decreased incidence of tumors and tumor growth. For this reason, macrophage function by itself can often accurately determine whether tumors will thrive or die.

Recognizing the Immune System’s Role in Fighting Cancer

Unlike conventional most conventional oncologists, alternative and integrative cancer doctors have long recognized the importance of the immune system when it comes to treating cancer effectively. For this reason, alternative and integrative doctors emphasize immune-boosting therapies as part of their overall strategy for addressing cancer. By contrast, most oncologists ignore immune function, focusing instead on simply killing cancer cells and tumors through the use of chemotherapy and/or radiation, both of which wreck havoc on cancer and healthy cells alike, especially immune cells. This difference in approach helps to explain why alternative and integrative approaches for cancer are often far more effective than conventional cancer treatments, both in the short-term and in the long-term.

What many people do not realize is that many cancer patients who are treated with chemotherapy or radiation actually do not die from their cancer, but from secondary infections such as pneumonia that are able to take hold in the body after conventional treatments have weakened and ravaged the immune system. That’s why helping to improve and maintain immune function is so vitally important when treating most cancers.

Alternative and integrative physicians accomplish this in a variety of ways, starting with improving their patients’ diet so that the foods they eat enhance all of the body’s functions, rather than impede them, which is what happens when you eat the nutritionally deficient standard American diet (SAD). Other therapies that may be employed to bolster the immune system are nutritional and orthomolecular medicine, herbal medicine, detoxification therapies, hyperthermia (heat-based therapies), and mind/body medicine (for stress relief and to heal painful emotions), to name just a few.

In addition, alternative cancer specialists, should they deem that chemotherapy or radiation is necessary, will use lab tests to help them determine the most appropriate chemo drugs to use that are most specific to each patient’s needs. By tailor-making chemotherapy treatments to match each individual’s unique needs, the chemo drugs that are employed are usually able to be administered at far lower doses than normal because they have been screened for their effectiveness. This not only increases their usefulness, but it also dramatically reduces the otherwise harmful side effects chemotherapy is noted for, sparing the immune system from harm.


The Cancer Establishment Is Catching On But Is It Enough?

Over the past few years drug companies and the mainstream cancer establishment has at long last begun to consider the immune system as part of their approach to treating cancer. Earlier this year, for example, an immune-stimulating cancer drug called Yervoy (ipilimumab) was hailed as “breakthrough” drug for combating late-stage melanoma, the deadliest form of skin cancer. Developed by Bristol-Meyers Squibb, it has been approved by the FDA after studies showed that it nearly doubled the number of melanoma patients who survived for three years or more. Since its approval, the drug industry has increased its research into developing other immune-boosting drugs for cancer.

However, the news is not all good. In fact, some of it is downright frightening. That’s because in clinical trials nearly 13% of patients taking Yervoy had severe or fatal autoimmune reactions. In addition, the drug also causes a wide range of side effects, including fatigue, hormone deficiencies, diarrhea, skin rash, and colitis (inflammation of the intestines. Moreover, like many cancer drugs, it is expensive. Plus, because it is new to market, no studies exist showing whether it is safe and effective long-term.

While I applaud the cancer establishment for finally beginning to research immune-boosting drugs, just as I agree that both chemotherapy and radiation have their place as part of physicians’ overall cancer-fighting arsenal, I question the wisdom of relying on drug-based immune-boosting approaches that are not completely safe and also so expensive. Especially when proven safe and natural immune-boosting therapies, such as those I’ve mentioned above, already exist and have a long track record of efficacy.

That’s why I am such a strong proponent of cancer treatments that rely on the “best of both worlds” from both the alternative and conventional fields of medicine. And it’s also why I encourage all cancer patients to explore all of their options from both fields and to seek out doctors who are trained in how to best integrate them. There is no “magic bullet” when it comes to treating cancer, and there most likely never will be. But certainly your body’s immune system is a key part of the complete cancer care picture, and that’s a fact more cancer doctors and patients alike need to recognize.